Rosen Law Firm Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation - GOCO
Investigation of GoHealth, Inc.: The Rosen Law Firm is investigating potential securities claims against GoHealth, Inc. due to allegations of misleading business information that may have impacted shareholders.
Class Action Opportunity: Investors who purchased GoHealth securities may be eligible for compensation through a class action lawsuit without upfront costs, following significant stock declines after the company was charged with illegal kickbacks related to Medicare Advantage plans.
Trade with 70% Backtested Accuracy
Analyst Views on GOCO
About GOCO
About the author
GoHealth (GOCO) Announces Q3 Loss, Falls Short of Revenue Projections
Quarterly Performance: GoHealth reported a quarterly loss of $0.19 per share, significantly better than the expected loss of $2.06, marking a 90.78% earnings surprise. However, revenues of $34.19 million fell short of estimates by 67.05%.
Stock Performance: GoHealth shares have declined approximately 74.3% year-to-date, contrasting with a 16.5% gain in the S&P 500, raising concerns about the company's future stock performance.
Earnings Outlook: The current consensus EPS estimate for the upcoming quarter is $1.92, with revenues projected at $380.13 million. The stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Insurance - Life Insurance industry is currently in the top 20% of Zacks-ranked industries, suggesting that broader industry trends could significantly influence GoHealth's stock performance moving forward.
Brighthouse Financial (BHF) Rises 27.2%: Is There More Growth Potential for the Stock?
Brighthouse Financial Stock Surge: Brighthouse Financial (BHF) shares surged 27.2% to $57.59, driven by acquisition news from Aquarian Holdings and increased trading volume, contrasting with a 2.5% loss over the past month.
Growth and Earnings Outlook: The company is focusing on enhancing its life insurance and annuity products, with expected quarterly earnings of $5.06 per share, reflecting a 26.8% year-over-year increase, and a revenue forecast of $2.25 billion, up 3.3% from last year.
